Assessment of a Pre-Workout Dietary Supplement (NB1)

October 30, 2016 updated by: Texas A&M University

Pharmacokinetic, Thermogenic, Hemodynamic, Ergogenic Assessment of a Pre-Workout Dietary Supplement

The purpose of this study is to examine the acute effects of a pre-workout dietary supplement on energy metabolism, cardiovascular hemodynamics, blood metabolites and mental focus.

Study Overview

Detailed Description

A number of nutritional strategies have been developed to optimize nutrient delivery prior to exercise. This includes providing carbohydrate and a number of ergogenic nutrients prior to, during and/or following exercise. As a result a number of pre-workout supplements have been developed to increase energy availability, promote vasodilation and/or positively affect exercise capacity. The purpose of this study is to investigate the potential ergogenic value of acute ingestion of a pre-workout dietary supplement prior to exercise.

Study Type

Interventional

Enrollment (Actual)

31

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • College Station, Texas, United States, 77843
        • Exercise & Sport Nutrition Laboratory

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • you are an apparently healthy and recreationally active man or woman between the ages of 18 and 40;
  • you will need to have at least six months immediate prior history of resistance training on the bench press and leg press or squat;

Exclusion Criteria:

  • you have a history of treatment for metabolic disease (i.e., diabetes), hypertension, hypo-tension, thyroid disease, arrhythmia and/or cardiovascular disease;
  • you are currently using prescription medications;
  • you have an intolerance to caffeine and/or other natural stimulants;
  • you are pregnant or a lactating female or plan to become pregnant with the next month;
  • you have a history of smoking;
  • you drink excessively (i.e., 12 drinks per week or more);

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: C4 Extreme
One dose of 12 grams (powder mixed with water): 1500 mg beta alanine, 1000 mg creatine nitrate, 1000 mg arginine AKG, 250 mg vitamin C, 150 mg n-acetyle tyrosine, 135 mg caffeine, 7.5 mg l-dopa, 30 mg vitamin B3, 10 mg synephrine, 0.5 mg vitamin B6, 0.25 mg vitamin B9, 0.035 mg vitamin B12.
Pre-Workout Dietary Supplement
Active Comparator: C4 Extreme (without Advantra Z)
One dose of 12 grams (powder mixed with water): 1500 mg beta alanine, 1000 mg creatine nitrate, 1000 mg arginine AKG, 250 mg vitamin C, 150 mg n-acetyle tyrosine, 135 mg caffeine, 7.5 mg l-dopa, 30 mg vitamin B3, 0.5 mg vitamin B6, 0.25 mg vitamin B9, 0.035 mg vitamin B12.
Pre-Workout Dietary Supplement
Placebo Comparator: Placebo
One dose of flavored placebo (powder mixed with water)
Pre-Workout Dietary Supplement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Optimize nutrient delivery prior to exercise by assessing; cognitive function (i.e., Stroop Color and Word Test and Word Recall Test).
Time Frame: Three weeks
Three weeks
Optimize nutrient delivery prior to exercise by assessing Readiness to Perform Visual Analog Scale.
Time Frame: Three weeks
Three weeks
Optimize nutrient delivery prior to exercise by assessing Resting Energy Expenditure.
Time Frame: Three weeks
Three weeks
Optimize nutrient delivery prior to exercise by assessing Heart Rate.
Time Frame: Three weeks
Three weeks
Optimize nutrient delivery prior to exercise by assessing Blood Pressure.
Time Frame: Three weeks
Three weeks
Optimize nutrient delivery prior to exercise by assessing ECG.
Time Frame: Three weeks
Three weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Measure standard clinical chemistry panels in the blood to evaluate safety.
Time Frame: Three weeks
Three weeks
Measure Heart Rate to evaluate safety.
Time Frame: Three weeks
Three weeks
Measure Blood Pressure to evaluate safety.
Time Frame: Three weeks
Three weeks
Measure ECG to evaluate safety.
Time Frame: Three weeks
Three weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Richard B Kreider, PhD, Texas A&M University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2014

Primary Completion (Actual)

May 1, 2014

Study Completion (Actual)

May 1, 2014

Study Registration Dates

First Submitted

September 13, 2016

First Submitted That Met QC Criteria

October 30, 2016

First Posted (Estimate)

November 2, 2016

Study Record Updates

Last Update Posted (Estimate)

November 2, 2016

Last Update Submitted That Met QC Criteria

October 30, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • IRB2014-0022FX

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dietary Modification

Clinical Trials on C4 Extreme

Subscribe